Theriva Biologics, Inc. TOVX
AMEX · United States · Health Technology
$0.22500.00 (0.00%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.07 | -0.06 | -27.3% | +4.3%$0.23→$0.24 |
| Q3 2025 | 2025-11-12 | -0.45 | -0.38 | -18.4% | 0.0%$0.28→$0.28 |
| Q2 2025 | 2025-08-11 | -1.93 | -0.47 | -310.6% | — |
| Q1 2025 | 2025-05-14 | -1.55 | -1.56 | +0.6% | — |
| Q4 2024 | 2025-03-06 | -11.49 | -7.22 | -59.1% | — |
| Q2 2024 | 2024-08-13 | -10.75 | -4.75 | -126.3% | — |
| Q1 2024 | 2024-05-07 | -7.50 | -8.50 | +11.8% | — |
| Q4 2023 | 2024-03-25 | -8.25 | -8.25 | 0.0% | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.